Deciphering Curcumin Labels
Does your curcumin (turmeric) product provide 500 mg of curcuminoids, a clinically validated amount? CuraMed®, with clinically proven BCM-95® Curcumin, clearly identifies the amount of curcuminoids it contains (500 mg) on its supplement facts box. Unfortunately many other products are not as forthcoming.
See How Other Curcumin Products Compare to CuraMed®
CuraMed® with BCM-95® Curcumin
1 Softgel - 500 mg of PURE curcuminoids
Meriva® 1 Capsule (500 mg. of Meriva) = 95 mg of curcuminoids
Theracurmin™ 1 Capsule (300 mg of Theracurmin) = 30 mg of curcumin (yielding only 27 mg of curcuminoids)
Turmeric 1 Capsule (500 mg of Turmeric) = about 20 mg of curcumin (yielding only 10-25 mg of curcuminoids)
See Sample Labels Below
CuraMed, BCM-95® Curcumin
• Clinically studied
• BCM-95® provides superior bioavailability
• High antioxidant ORAC value > 1,000,000**
• Healthy inflammation response*
A patent-pending method using small particle size, turmeric essential oil, and phospholipids ensures that CuraMed® delivers a curcumin that is up to 10 times more bioavailable than curcumin 95%, and 6.3 times more bioavailable than curcumin with lecithin and piperine, as well has having an 8-12 hour retention time in the body. The result is a high-potency formula providing superior support for a healthy inflammation response, a healthy immune and cardiovascular system, and resistance to free radical activity.* BCM-95® bioavailable curcumin Call to Order 513-737-4053
Curcumin BCM-95 is a patented complex of curcumin 95%, homogenized with turmeric essential oil and then complexed with phospholipids for greater absorption. Human clinical studies have shown it to be absorbed up to 10 times greater than standard curcumin 95%.
All of EuroPharma's formulations have a high concentration of curcumin that presents a meaningful level of curcumin. No other company on the market can reach the level of absorbable curcumin nor offer dosages that are comparable to curcumin BCM-95.
Turmeric, Curcumin and BCM-95® Curcumin
To obtain 1 gram of curcumin, you will need to take 20 to 50 grams of turmeric. Therefore, curcumin compared to turmeric is about a 20 to 50 fold difference. This does not mean you will ABSORB the curcumin; this is the amount of turmeric it takes to yield a gram of curcumin.
Curcumin is the extract of turmeric, and is generally standardized to 95% curcumin. It is poorly absorbable. Early curcumin studies required 8 to 12 grams of curcumin to raise curcumin blood levels into a therapeutic range. This translates to 16 to 24 capsules per day.
BCM-95® Curcumin is developed with a patented process utilizing micronization and essential turmeric oils. Published human studies have shown that BCM-95 Curcumin absorbs 8 to 10 times better than plain curcumin, and maintains serum levels in the clinically desirable range for more than 8 to 12 hours. The dosage needed to replicate serum levels in earlier studies would be 1 to 2 capsules per day.
The proper product comparison is curcumin to curcumin. However, since many companies are comparing their curcumin absorption to turmeric, we provide this information as a service to our customers.
Plain curcumin 95% compared to turmeric delivers 20 to 50 times the curcumin as the same amount of turmeric.
BCM-95 Curcumin has been proven to deliver 8 to 10 times more curcumin into the bloodstream as the same amount of plain curcumin.
Therefore, when compared gram per gram, BCM-95 Curcumin delivers 8 to 10 times more curcumin than plain curcumin 95% and 160 to 500 times more curcumin than that found in an equal amount of turmeric.
Why Should Curcumin BCM-95® Be Your Preferred Source of Curcumin?
- Enhanced oral bioavailability of curcumin in the blood up to 7 to 10 times that of curcumin 95%, based on published human trials
- A patented 100% natural turmeric extract (3 U.S. Patents awarded)
- Proprietary blend of curcuminoids and essential oil of turmeric
- Full spectrum of natural curcuminoids
- Extended retention of curcumin in the blood up to 8 to 12 hours
- Proven by scientific and human clinical studies
- High ORAC value >13,000 per gram
Studies on BCM-95® Curcumin
- Human Clinical Study to evaluate the bioavailability of BCM-95 (Published: September 2006 Spice India pg 11-16)
- A Pilot Cross-Over Study to evaluate human oral bioavailability of BCM-95, A Novel Bioenhanced Preparation of Curcumin (Published: Indian Journal of Pharmaceutical Sciences July-Aug 2008 pg 445-450)
- Six-Month Randomized Placebo-Controlled, Double-Blind, Pilot Clinical Trial of Curcumin in Patients with Alzheimer's Disease (Published: Journal of Clinical Psychopharmacology, Vol 28, Number 1, Feb 2008 pg 110-114)
- Curcumin effects on Blood Lipid profile in a 6-month human Study (Published: Elsevier Pharmacological Research 56(2007) pg 509-514.)
- Oral Bioavailability of BCM-95 in Dogs. (Poster presentation. 2009 ACVIM Forum/Canadian VMA
- Convention: June 3-6, 2009; Montréal, Québec, Canada)
- Toxicity study: BCM-95® curcumin does not cause toxicity even at 75 mg/110 gm weight dosed
for 45 days.
- BCM-95 Hepatoprotective (liver protective) Effect. Department of Biochemistry, University of Kerala.
Current Studies Under Peer Review for Publications:
- Randomized, Controlled Human Clinical Study to Assess the efficacy and safety of BCM-95 & BosPure compared to Celecoxib in the management of Knee Osteoarthritis. Dose: 500 mg blend BCM-95 Curcumin and BosPure Bosellia twice daily vs 100 mg celecoxib (brand name Celebrex®) twice daily.
- Randomized, Controlled Human Clinical Study to Assess the efficacy and safety of BCM-95 compared to Diclofenac Sodium (brand name Voltaren®) in the management of Active Rheumatoid Arthritis.
- BCM-95 vs. fluoxetine (brand name Prozac®) for antidepressant effects.
Current-Ongoing Clinical Studies:
- Phase II randomized, multi-center, double-blind, placebo chemoprevention clinical trial of [BCM-95] curcumin in oral premalignant lesions and cervical cancer.
- Martins R. Evaluation of the nutritional extract Bio-curcumin (BCM-95) to preserve cognitive functioning in a cohort of mild cognitively impaired (MCI) patients over 12 months. Edith Cowan University. Joondalup, Western Australia.
- Bioavailability in healthy human volunteers: Baylor University, Texas.
- Pilot study: Comparison of 5 curcumin types in vitro: phosphatidylcholine (lecithin) bound curcumin in 4 to 1 ratio, BCM-95® curcumin, synthetic curcumin, bisdemethoxycurcumin, plain 95% curcumin. Baylor University, Texas.
- BCM-95® curcumin impact on "sleeping gene" as partial mechanism of action for cancer prevention. Baylor University, Texas.
- Effective curcumin on combination with anti-seizure drugs in reduced seizure activity and memory retention.